MedTrace Logo

TMS for Anxiety and Trauma-related Disorders

NCT06475040 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2024-07-10

No results posted yet for this study

Summary

The present pilot study will apply accelerated intermittent theta burst stimulation (aiTBS) to a novel transcranial magnetic stimulation (TMS) target for anxiety derived via causal network mapping.

Conditions

  • Anxiety Symptoms
  • Anxiety Disorders

Interventions

DEVICE

transcranial magnetic stimulation

non-invasive form of brain stimulation accelerated intermittent theta burst stimulation (aiTBS)

Sponsors & Collaborators

  • Brigham and Women's Hospital

    collaborator OTHER

  • Shanghai Mental Health Center

    lead OTHER

Principal Investigators

  • Huiru Cui, Ph.D · Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-19
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06475040 on ClinicalTrials.gov